Chinese University of Hong Kong: Stomach Neoplasms trials

The registry lists 13 Stomach Neoplasms studies with Chinese University of Hong Kong as lead sponsor. 6 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 1Phase 3 6No phase 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Identification of Therapeutic Targets in Metastatic Gastric CancerRecruitingNCT07551440
• The UGIRA International Registry for RAMIG for Gastric CancerRecruitingNCT07517432
• Robotic Gastrectomy With 5th ArmRecruitingNCT07310888Not applicable
• Perioperative FLOT vs Adjuvant XELOX for CA StomachRecruitingNCT05264896Phase 3
• Prediction of Gastric Cancer in Intestinal Metaplasia and Atrophic GastritisRecruitingNCT04840056
• AG & IM in CA Stomach ProtocolRecruitingNCT04184960
• RCT of Gastric ESD With or Without Epineprhine Added SolutionCompletedNCT04032119Phase 3
• The Impact of Enhanced Recovery After Surgery (ERAS) Program on Clinical and Immunological Outcomes for Minimally-invasive GastrectomyStatus unknownNCT03160924Phase 3
• Prospective Randomized Trial Comparing Endoscopic Submucosal Dissection Against Laparoscopic Assisted Gastrectomy for Treatment of Early Gastric CancerCompletedNCT03136354Not applicable
• Gastric Cancer RAD001 StudyCompletedNCT01514110Phase 1/2
• Selective COX-II Inhibitor as a Palliative Therapy in Patients With R1 or R2 Resection for Disseminated Stomach Cancer - A Multi-Centre Prospective Randomized Controlled TrialStatus unknownNCT00165048Phase 3
• Role of Routine Nasogastric Decompression After Subtotal GastrectomyStatus unknownNCT00164918Phase 3
• Selective COX-II Inhibitor as an Adjuvant Therapy in Patients With Resectable Advanced Stomach Cancer ( Histological Staging ≥ T2N1) - A Multi-Centre Prospective Randomised Controlled TrialStatus unknownNCT00164892Phase 3